Latest Biotech News

Recursion Pharmaceuticals announced a 20% workforce reduction reflecting ongoing pipeline pruning and difficulties in securing capital given current biotech financing climates, signaling...

Insilico Medicine launched its Nach01 foundation AI model via AWS Marketplace, enabling superior molecular prediction and retrosynthesis capabilities to accelerate drug discovery pipelines, making...

Merck & Co. secured FDA approval for Enflonsia (cesrovimab), a monoclonal antibody preventing respiratory syncytial virus in infants. This approval arrives amidst the unprecedented removal of the...

Amid severe changes including the termination of over $9 billion in NIH grants and dismissal of the CDC’s vaccine advisory committee (ACIP), hundreds of NIH scientists have issued the Bethesda...

Innovations in cancer therapy include Antares Therapeutics’ $177 million raise following its spinout from Scorpion Therapeutics and Nagoya University’s development of next-generation CAR-T cells...

SpliceBio secured a $135 million Series B round to advance its dual AAV gene therapy candidate SB-007 for Stargardt disease despite a challenging funding environment. Meanwhile, National...

The field of stem cell-based embryo models (SCBEM) is rapidly advancing, prompting updated ethical and regulatory oversight recommendations to ensure responsible research. In parallel, innovative...

A novel telehealth-driven supportive care program, GAIN-S, delivered personalized geriatric oncology interventions remotely, mitigating geographical and resource barriers in Brazil. The randomized...

Researchers developed a novel penicillin variant that remains inactive until triggered by green light, enabling precise spatial and temporal control over antibiotic activity. This...

Insmed's phase IIb trial of treprostinil palmitil inhalation powder (TPIP) for pulmonary arterial hypertension delivered a significant 35% placebo-adjusted reduction in pulmonary vascular...

Artificial intelligence continues revolutionizing biotech R&D, with companies like Insilico Medicine unveiling advanced foundation models (Nach01) for generative chemistry applications, and...

The U.S. FDA has approved Merck's monoclonal antibody Enflonsia (cesrovimab) to prevent respiratory syncytial virus lower respiratory tract disease in infants, positioning it as a competitor to...

AI-driven drug discovery company Recursion Pharmaceuticals announced a 20% workforce reduction following strategic pipeline pruning and funding constraints faced amid biotech capital market...

Innovative nanoparticle vaccine formulations targeting pancreatic ductal adenocarcinoma demonstrated remarkable efficacy in preclinical mouse models, achieving complete tumor clearance in over...

In an unprecedented move, U.S. Health Secretary Robert F. Kennedy Jr. removed all 17 members of the CDC’s Advisory Committee on Immunization Practices, responsible for guiding national vaccine...

Cutting-edge studies elucidate critical aspects of cancer metabolism and microenvironment interactions. Disruption of lipid and phospholipid metabolism in Parkinson’s brains parallels tumor...

Significant strides are being made in infectious disease management and vaccine development. Merck’s monoclonal antibody Enflonsia received FDA approval to prevent infant RSV infection, entering...

Emerging research uncovers intricate connections in neurological and metabolic diseases. Studies identify accelerated biological aging markers in pediatric multiple sclerosis patients, offering...

Advances in environmentally focused biotech solutions are expanding. Scientists developed a solar-powered system converting plastic waste into clean hydrogen fuel, addressing pollution and energy...

Significant upheaval is underway in U.S. public health governance. Health Secretary Robert F. Kennedy Jr. controversially dismissed all 17 members of the CDC’s Advisory Committee on Immunization...